SCHEMBL8286238

SCHEMBL8286238

CCOC(=O)c1ccc2c(c1)nc(NC(=O)OC)n2Cc1nc(C)ccc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.47
SIRT2 Q8IXJ6 6/20 0.46
MAPT P10636 3/20 0.46
NPC1 O15118 2/20 0.46
NLRP3 Q96P20 1/20 0.46
SIRT1 Q96EB6 4/20 0.45
RAB9A P51151 2/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
HPGD P15428 3/20 0.44
ALDH1A1 P00352 3/20 0.44
NPSR1 Q6W5P4 2/20 0.42
ATM Q13315 1/20 0.42
PTGER4 P35408 1/20 0.42
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286239 0.92 ALDH1A1 (0.44) KDM4ESIRT2MAPTNPC1NLRP3
SCHEMBL8284696 0.84 SIRT2 (0.48) KDM4ESIRT2MAPTNPC1NLRP3
SCHEMBL8294218 0.83 MAPT (0.49) KDM4ESIRT2MAPTNPC1NLRP3
SCHEMBL8292577 0.80 TRPC5 (0.48) KDM4ESIRT2MAPTSIRT1MEN1
SCHEMBL8294762 0.80 SIRT2 (0.43) KDM4ESIRT2MAPTSIRT1MEN1
SCHEMBL8255842 0.79 NPC1 (0.45) KDM4ESIRT2MAPTNPC1NLRP3
SCHEMBL12852043 0.79 SSTR5 (0.50) PTGER4
SCHEMBL14002580 0.79 KDM4E (0.51) KDM4ESIRT2MAPTSIRT1MEN1
SCHEMBL8294800 0.79 TRPC5 (0.38) KDM4ESIRT2MAPTNPC1NLRP3
SCHEMBL8284625 0.77 CA12 (0.46) KDM4ESIRT2MAPTNPC1NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044073-B2 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication TIBOTEC PHARMACEUTICALS (IE) 2011-10-25 US disclosed
US-8044073-B2 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication TIBOTEC PHARMACEUTICALS (IE) 2011-10-25 US disclosed
EP-1697343-B1 AMINOBENZIMIDAZOLES AND BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION TIBOTEC PHARM LTD (IE) 2009-07-01 EP disclosed
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication JANSSEN SCIENCES IRELAND UC (IE) 2007-05-03 US disclosed
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication JANSSEN SCIENCES IRELAND UC (IE) 2007-05-03 US disclosed
WO-2005058869-A1 AMINOBENZIMIDAZOLES AND BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION TIBOTEC PHARMACEUTICALS LTD. (IE) 2005-06-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-2, H1-4 KDM4E 704/4885SIRT2 1767/4885MAPT 4517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.